Elray Resources has announced a "significant milestone" in the company’s growth strategy.
Elray has completed the sale of proprietary technology to 180 Life Sciences Corp, a NASDAQ listed company, in exchange for preferred stock convertible into a 40 per cent stake in ATNF and warrants to purchase three million shares of ATNF common stock.
The technology stack contained within Elray’s technology package will assist ATNF in launching an igaming blockchain casino.
“This strategic sale and potential future partnership are expected to enhance Elray’s financial position, support future innovation and open new opportunities and revenue streams for the company,” said Vincent Cai, CTO of Elray Resources.
“This will not only strengthen our balance sheet considerably, but also will enable ATNF and Elray to collaborate with leading players in the market.
"We look forward to announcing relationships with new operators, which will deliver even greater value to shareholders and propel our business forward.”
